Pancreatic Cancer Research

ResearcherSun Yat-sen UniversityActive in the last 2 years

Tuo Hu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7069-1466; OpenAlex author ID A5038093175. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
0
Labs led
0
Collaborators
47
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 2 papers · 2025: 1 paper · 2026: 2 papers

Papers 8

  1. KRAS Signaling Inhibition Induces a Targetable Metabolic Dependency on Lipophagy-Dependent Fatty Acid Oxidation in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-24-1984↗
  2. Systemic immunosuppression limits NK cell therapy efficacy in pancreatic cancer. Co-author DOI 10.1186/s12943-025-02340-8↗
  3. SIK1 promotes ferroptosis resistance in pancreatic cancer via HDAC5-STAT6-SLC7A11 axis. Co-author DOI 10.1016/j.canlet.2025.217726↗
  4. Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2-SP1-SAT1 axis. Co-author DOI 10.1038/s41556-024-01372-4↗
  5. Author Correction: Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2-SP1-SAT1 … Co-author DOI 10.1038/s41556-024-01417-8↗
  6. The m7G Reader NCBP2 Promotes Pancreatic Cancer Progression by Upregulating MAPK/ERK Signaling. Co-author DOI 10.3390/cancers15225454↗
  7. MARK2 regulates chemotherapeutic responses through class IIa HDAC-YAP axis in pancreatic cancer. Co-author DOI 10.1038/s41388-022-02399-3↗
  8. Metabolic Rewiring by Loss of Sirt5 Promotes Kras-Induced Pancreatic Cancer Progression. Co-author DOI 10.1053/j.gastro.2021.06.045↗

Closest collaborators

The 25 strongest of 47 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kamiya Mehla · 5 shared papers, 2021–2026 · strength 0.81
  2. Chunbo He · 5 shared papers, 2021–2026 · strength 0.81
  3. Ravi Kumar Thakur · 5 shared papers, 2021–2026 · strength 0.81
  4. Surendra Kumar Shukla · 5 shared papers, 2021–2026 · strength 0.81
  5. Pankaj Kumar Singh · 5 shared papers, 2021–2026 · strength 0.72
  6. Ryan J. King · 4 shared papers, 2021–2026 · strength 0.59
  7. Sai Sundeep Kollala · 3 shared papers, 2024–2026 · strength 0.50
  8. Michael Anthony Hollingsworth · 3 shared papers, 2024–2026 · strength 0.50
  9. Susanna Varkey Ulahannan · 3 shared papers, 2024–2026 · strength 0.50
  10. Divya Murthy · 3 shared papers, 2021–2024 · strength 0.36
  11. Nina V. Chaika · 3 shared papers, 2021–2024 · strength 0.36
  12. Scott E. Mulder · 3 shared papers, 2021–2024 · strength 0.36
  13. Kuldeep Singh Attri · 3 shared papers, 2021–2024 · strength 0.36
  14. Jiancong Xie · 2 shared papers, 2023–2025 · strength 0.36
  15. Weidong Pan · 2 shared papers, 2023–2025 · strength 0.36
  16. Jing Chen · 2 shared papers, 2023–2025 · strength 0.36
  17. Rosa F. Hwang · 2 shared papers, 2024 · strength 0.28
  18. Ajay Jain · 2 shared papers, 2024 · strength 0.28
  19. Vikrant Rai · 2 shared papers, 2024 · strength 0.28
  20. Aneesha Dasgupta · 2 shared papers, 2024 · strength 0.28
  21. Robert Powers · 2 shared papers, 2024 · strength 0.28
  22. Teklab Gebregiworgis · 2 shared papers, 2024 · strength 0.28
  23. Joshua J. Souchek · 2 shared papers, 2024 · strength 0.28
  24. Barish H. Edil · 2 shared papers, 2024 · strength 0.28
  25. Kathryn Elaine Wellen · 2 shared papers, 2024 · strength 0.28

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.